Source: CENTR Brands.
  • Last month, CENTR (CNTR) added over 350 locations to its growing U.S. retail presence
  • CENTR, CENTR Sugar Free and CENTR Instant can now be found in more than 3,400 U.S. retail locations
  • The company is confident that it will replicate its success as new products flow through its development pipeline
  • CENTR Brands is one of North America’s leading functional beverage companies
  • CENTR (CNTR) is up by 7.69 per cent trading at $0.70 per share

Last month, CENTR (CNTR) added over 350 locations to its growing U.S. retail presence.

CENTR, CENTR Sugar Free and CENTR Instant can now be found in more than 3,400 U.S. retail locations.

The company intends to expand into non-CBD beverages in the future.

“We are incredibly excited about the growth CENTR continues to achieve across the U.S. as we expand our leadership position in the sparkling CBD beverage category,” said Joseph Meehan, CENTR’s CEO.

“CENTR continues to distinguish itself from other leaders in the category as a supplier of innovative wellness options, with CENTR’s CBD sparkling waters recognized as the number-one-selling CBD beverage in the U.S.,” added David Young, CENTR’s CFO. “As the company continues to introduce new brands catering to the growing demand of this intentional and wellness-oriented consumer base, we expect to replicate its dominance and leadership with each new product rollout.”

CENTR Brands is one of North America’s leading functional beverage companies.

CENTR (CNTR) is up by 7.69 per cent trading at $0.70 per share as of 1:15 pm EST.

More From The Market Online

Odd Burger to add 40 locations in Florida

Odd Burger (TSXV:ODD) will develop 40 new locations in Florida over the next eight years, with its sights set on further U.S. expansion.

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.